360biolabs Pty Ltd

Site

360biolabs

Accreditation No.

15805

Site No.

17036

Date of Accreditation

12 Apr 2010

Address

85 Commercial Road
Melbourne, VIC 3004
Australia

360biolabs.com

Contact

Ms Angela Luttick P: +61 (03) 92822184

Availability

Services conditionally available to external clients

Scope of Accreditation

Print scopes
360biolabs

ISO/IEC 17025 (2017)

Healthcare, Pharmaceutical and Media Products

Service Product Determinant Technique
Analysis in support of clinical trials and/or pre-clinical studies Animal biological samples; Human biological samples Impact of pharmaceuticals, biological agents and vaccines on disease and treatment outcomes; Pharmacodynamics (PD) parameters; Pharmacokinetic (PK) parameters ELISpot assays; Enzyme linked immunosorbent assay (ELISA); Flow cytometry; Haemagglutination inhibition assays; Isolation and cryopreservation of mononuclear cells, plasma and serum; LC-MS-MS; Measurement of infectious titre - TCID50 and plaque assays; Multiplex assays; Neutralisation activity assays; PCR - Quantitative (qPCR); Viral culture immunogenicity testing - Anti-drug antibodies (ADA); Virus genotyping; Virus molecular typing by polymerase chain reaction (PCR) and sequencing; Virus phenotyping (including measurement of anti-infective activity via cytopathic effect, enzyme and plaque reduction assays); Virus/drug/matrix stability assays

Capability

Projects are managed in accordance with the GCLP Principles interpreted for research.

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.